Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Gamida Cell Ltd.
  6. News
  7. Summary
    GMDA   IL0011552663

GAMIDA CELL LTD.

(GMDA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Gamida Cell Plans Rolling Submission of Biologics License Application for Bone Marrow Transplant Product; Shares Rise Pre-Bell

01/19/2022 | 07:56am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about GAMIDA CELL LTD.
04:31pGamida Cell to Present Corporate Highlights at the H.C. Wainwright Global Life Sciences..
BU
05/12GAMIDA CELL LTD. Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/10TRANSCRIPT : Gamida Cell Ltd., Q1 2022 Earnings Call, May 10, 2022
CI
05/10Gamida Cell Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/10Gamida Cell Reports First Quarter 2022 Financial Results and Provides Company Update
BU
05/05Gamida Cell Presents New Data from NAM-Enabled Genetically Modified Natural Killer (NK)..
BU
05/05Gamida Cell Presents New Data from NAM-Enabled Genetically Modified Natural Killer (NK)..
CI
05/03Gamida Cell Announces the Date of Its First Quarter 2022 Financial Results and Webcast
BU
04/27Gamida Cell Presents Updated One-Year Post-Transplant Follow Up Data from Phase 3 Study..
BU
04/27Gamida Cell Ltd. Presents Updated One-Year Post-Transplant Follow Up Data from Phase 3 ..
CI
More news
Analyst Recommendations on GAMIDA CELL LTD.
More recommendations
Financials (USD)
Sales 2022 1,85 M - -
Net income 2022 -78,4 M - -
Net Debt 2022 62,0 M - -
P/E ratio 2022 -1,92x
Yield 2022 -
Capitalization 141 M 141 M -
EV / Sales 2022 110x
Capi. / Sales 2023 4,19x
Nbr of Employees 167
Free-Float 69,8%
Chart GAMIDA CELL LTD.
Duration : Period :
Gamida Cell Ltd. Technical Analysis Chart | GMDA | IL0011552663 | MarketScreener
Technical analysis trends GAMIDA CELL LTD.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 2,36 $
Average target price 13,83 $
Spread / Average Target 486%
EPS Revisions
Managers and Directors
Julian Adams Chief Executive Officer & Director
Shai Lankry Chief Financial Officer
Robert I. Blum Chairman
Ronit Simantov Chief Medical & Scientific Officer
Yona Geffen Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
GAMIDA CELL LTD.-7.09%141
GILEAD SCIENCES, INC.-14.28%78 068
REGENERON PHARMACEUTICALS, INC.3.72%70 575
VERTEX PHARMACEUTICALS15.74%65 005
WUXI APPTEC CO., LTD.-16.20%42 275
BIONTECH SE-41.35%36 745